Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference

Rhea-AI Summary

Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), Canada's largest medical cannabis company, has announced its participation in TD Cowen's 9th Annual Future of the Consumer Conference in New York City. CFO Simona King will engage in a fireside chat and investor meetings on June 3, 2025, at 2:45pm EST.

The discussion, hosted by TD Cowen's VP of Equity Research Derek Lessard, will focus on Aurora's international market expansion, medical cannabis landscape developments, Canadian manufacturing progress, and market dynamics. A live audio webcast will be available, with replay access for approximately 90 days through Aurora's investor relations website.

NASDAQ | TSX: ACB

Canada's Largest Medical Cannabis Company to Discuss Key Trends, Market Opportunities and the Future of the Global Cannabis Industry

EDMONTON, AB, May 27, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 9^th Annual Future of the Consumer Conference in New York City, NY. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on June 3, 2025, at 2:45pm EST.

Conference Call Details

DATE: Tuesday, June 3

TIME: 2:45pm Eastern Time | 12:45pm Mountain Time

WEBCAST: Click Here

The fireside chat will be hosted by Derek Lessard, VP of Equity Research at TD Cowen. The discussion will cover Aurora's recent international market growth, evolution of the medical cannabis landscape, Canadian manufacturing advancements and overall market dynamics.

To listen to the live audio webcast, please register using the weblink above, which has also been posted to the Company's "Investor Info" section at https://www.auroramj.com/investors/ under "Events". A replay of the presentation will be available using the same link for approximately 90 days.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Contact

For Media: Michelle Lefler | VP, Communications & PR | media@auroramj.com

For Investors: ICR, Inc. | aurora@icrinc.com

Forward Looking Information  

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's participation in TD Cowen's annual Future of the Consumer Conference, including the date, time, location and topics for discussion.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-to-participate-in-td-cowens-9th-annual-future-of-the-consumer-conference-302464904.html

SOURCE Aurora Cannabis Inc.

FAQ

When is Aurora Cannabis (ACB) presenting at TD Cowen's Consumer Conference 2025?

Aurora Cannabis will present at TD Cowen's conference on June 3, 2025, at 2:45pm Eastern Time (12:45pm Mountain Time).

Who will represent Aurora Cannabis at the TD Cowen conference?

Simona King, Aurora Cannabis's Chief Financial Officer, will represent the company at the conference.

What topics will Aurora Cannabis (ACB) discuss at the TD Cowen conference?

The discussion will cover Aurora's international market growth, medical cannabis landscape evolution, Canadian manufacturing advancements, and overall market dynamics.

How can investors access Aurora Cannabis's presentation at the TD Cowen conference?

Investors can access the live audio webcast through Aurora's investor relations website at auroramj.com/investors under 'Events'. A replay will be available for approximately 90 days.